AGP Executive Report
Last update: 12 hours agoInsurance Premiums: Washington approved a 22.2% average individual health insurance rate increase for 2027, citing rising care costs and stronger needs; open enrollment starts Nov. 1. Cancer Drug Update: The FDA granted accelerated approval expansion for Bayer’s sevabertinib (Hyrnuo) for untreated HER2-mutant locally advanced/metastatic non-squamous NSCLC, with continued first-line approval tied to an ongoing phase 3 trial. Pharmacy Admin Pressure: A Pharmacy Benefit Management Institute session highlighted that “transparency” alone won’t fix pharmacy benefit disruption; practices say prior authorization got slower after a federal 2026 clock. Data Privacy Risk: AWKO Law is investigating an Aesto Health breach affecting about 9.54 million patient records, raising fresh concerns for healthcare data handling. Women’s Health Supply: After months of estrogen patch access problems, the FDA says it’s working with six manufacturers to boost supply and urges clinicians to discuss alternatives. Rural Care Funding: HHS awarded nearly $25M to 132 rural hospitals to strengthen staffing and keep services open. Health Tech & Operations: Samsung Biologics signed a $262M manufacturing deal for a European pharma client and is expanding capacity in Songdo. Behavioral Health Workforce: Nichols College launched a flexible master’s in mental health counseling to address counselor shortages. Transportation Access: Crown Care NEMT rolled out nationwide private-pay medical transport with online booking and fast confirmations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.